About Us
Empowering growth through CDMO-CMO Partnership
Cadila Pharmaceuticals Ltd. is one of the largest privately-held pharmaceutical companies in India. Over the past seven decades, we have been developing and manufacturing affordable medicines for patients around the world.
CPL-Pharma: Unlock your potential
At the forefront of pharmaceutical innovation, we are a trusted API CDMO partner—supporting global healthcare companies in bringing life-saving therapies to patients faster, safer, and smarter.
CPL-Pharma (Division of Cadila Pharmaceuticals Ltd.) is a science-led contract research, development, and manufacturing organization (CRDMO) committed to accelerating the journey from molecule to market to accelerating the journey from molecule to market. We offer product and services—from early-stage discovery to commercial manufacturing—we help bring life-changing therapies to patients.
Vision
To be recognized as a global leader in API and CDMO services, delivering breakthrough healthcare solutions through science, innovation, and operational excellence.
Values
We are driven by Integrity, Innovation, Sustainability, and Customer-Centric Collaboration—principles that guide our every decision and partnership.
Promise
With global delivery capabilities and a collaborative mindset, we ensure long-term partnerships built on trust, innovation, and a shared commitment to success.
Potential That Speaks Confidence
From Discovery to Delivery
- We offer product and services—from early-stage discovery to commercial manufacturing—we help bring life-changing therapies to patients.
- At the forefront of pharmaceutical innovation, we are a trusted CDMO partner offering large scale manufacturing for API, intermediates and KSM.
- We specialize in the development and manufacturing of Active Pharmaceutical Ingredients and offer end-to-end support from process development to commercial-scale production, under strict regulatory compliance, focusing on Phase I, II & III and commercial projects for New Chemical Entities ( NCEs).
- Our facilities are approved by global regulatory agencies like USFDA, EDQM (Europe), TGA(Australia), PMDA (Japan), KFDA (Korea), WHO (Geneva) and ANVISA (Brazil).
- With global delivery capabilities and a collaborative mind-set, we don’t just manufacture—we co-create success - From clinical phases to commercialization, we’re your long-term partner in pharmaceutical innovation.
Board Members & Leadership
A strong team comprising business and industry veterans guides the company’s growth trajectory and has enabled the company to attain a leadership position.
